Senaste försöken

EudraCT Number: 2005-000346-36

Sponsor Protocol Number: BPLG-004

Start Date:

Sponsor Name: BioPartners GmbH [...] 1. BioPartners GmbH 2. LG Life Science Ltd.

Full Title: A Phase III, Multi-centre, Randomised, Parallel Group Study of Safety and Efficacy of the LB03002 a New Sustained Release Formulation of Human Recombinant Growth Hormone as Compared to Standard Dai...

Medical condition: pre-pubertal drug naïve growth-deficient children with insufficient endogenous growth hormone secretion

Disease:	Version	SOC Term	Classification Code	Term	Level
			10056438		LLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: AT (Completed) FI (Prematurely Ended) SE (Prematurely Ended) SK (Completed) HU (Completed) CZ (Prematurely Ended) IT (Completed) DE (Completed) LT (Prematurely Ended) EE (Prematurely Ended) LV (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2008-004093-40

Sponsor Protocol Number: 08-PIR-03

Start Date:

Sponsor Name: Nektar Therapeutics

Full Title: A Multicenter, Open-Label, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 (PEG-Irinotecan) Versus Irinotecan in Patients with Second-Line, Irinotecan-Naïve, KRAS-Mutant, ...

Medical condition: Refractory Solid Tumors (Colorectal Cancer) Tumores sólidos refractarios (Cáncer colorrectal)

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10061451	Colorectal cancer	LLT
	9.1		10065147	Malignant solid tumor	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) BE (Prematurely Ended) DE (Completed) GB (Completed) SK (Completed) LV (Completed)

Trial results: View results

EudraCT Number: 2021-002686-18

Sponsor Protocol Number: EP0162

Start Date:

Sponsor Name: UCB Biopharma SRL

Full Title: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Olde...

Medical condition: Treatment of stereotypical prolonged seizure

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029205 - Nervous system disorders	10076333	Prolonged seizure	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) IT (Ongoing) FR (Ongoing) HU (Ongoing) CZ (Ongoing) ES (Ongoing) PL (Ongoing) BG (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-020386-24

Sponsor Protocol Number: TRO19622CLEQ1275-1

Start Date:

Sponsor Name: TROPHOS SA

Full Title: Phase II, multicenter, randomized, adaptive, double-blind, placebo controlled study to assess safety and efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients.

Medical condition: Spinal Muscular Atrophy (type 2 or type 3 non ambulant patients aged 3-25 years)

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10041582	Spinal muscular atrophy	LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Ongoing) NL (Completed) BE (Completed) DE (Completed) IT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2012-004586-41

Sponsor Protocol Number: CHUBX2012/16

Start Date:

Sponsor Name: CHU de Bordeaux

Full Title: Cognitive remediation in Attention Deficit Disorder with or without Hyperactivity (ADHD) children : Comparison between three therapeutic strategies : cognitive remediation with a virtual classroom ...

Medical condition: Attention Deficit Disorder with or without Hyperactivity

Disease:	Version	SOC Term	Classification Code	Term	Level
	16.0	100000004873	10003730	Attention deficit and disruptive behaviour disorders	HLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-002637-42

Sponsor Protocol Number: EP0165

Start Date:

Sponsor Name: UCB Biopharma SRL

Full Title: An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Se...

Medical condition: Treatment of stereotypical prolonged seizure

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029205 - Nervous system disorders	10076333	Prolonged seizure	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) ES (Ongoing) IT (Ongoing) FR (Not Authorised) HU (Ongoing) CZ (Ongoing) PL (Ongoing) BG (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-017267-41

Sponsor Protocol Number: CQAV680A2201E1

Start Date:

Sponsor Name: Novartis Pharma Services AG

Full Title: A randomized, double-blind, parallel group study to compare the pharmacodynamics/efficacy, safety and pharmacokinetics of QAV680 versus placebo in patients with moderate persistent asthma

Medical condition: Moderate persistent asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10003553	Asthma	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2009-014768-21

Sponsor Protocol Number: TUD-TEMDS1-042

Start Date:

Sponsor Name: Dresden Technical University

Full Title: Treatment of MDS patients with single agent temsirolimus – a pilot study

Medical condition: Myelodysplastic Syndromes (MDS) (20 IPSS LOW+INT-1 and 20 IPSS INT-2+HIGH or proliferating CMML)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10028533	Myelodysplastic syndrome	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2010-021792-81

Sponsor Protocol Number: 2010-12

Start Date:

Sponsor Name: ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE

Full Title: SFCE-Metro 01 : Etude de phase II de chimiothérapie métronomique associant celecoxib-methotrexate-vinblastine-cyclophosphamide chez les enfants porteurs d’une tumeur solide en rechute ou en progre...

Medical condition: children and adolescents with relapsed or progressing solid tumours.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-002270-29

Sponsor Protocol Number: IN 0401 INT

Start Date:

Sponsor Name: LEO Pharma A/S

Full Title: Safety profile of innohep versus subcutaneous unfractionated Heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis

Medical condition: Treatment of acute deep vein thrombosis in elderly patients with impaired renal function

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10051055		LLT

Population Age: Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) ES (Completed) DK (Prematurely Ended) BE (Completed) CZ (Prematurely Ended) BG (Prematurely Ended)

Trial results: View results

Senaste försöken

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner